Search Results for "days"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for days. Results 11 to 20 of 1849 total matches.
Estradiol/Progesterone (Bijuva) for Menopausal Vasomotor Symptoms
The Medical Letter on Drugs and Therapeutics • Jul 01, 2019 (Issue 1575)
with
moderate to severe vasomotor symptoms (≥7 episodes
per day or ≥50 per week) who were randomized to
1 of 4 ...
The FDA has approved Bijuva (TherapeuticsMD), a
fixed-dose combination of estradiol and progesterone,
for oral treatment of moderate to severe vasomotor
symptoms (hot flashes) due to menopause in women
with an intact uterus. The manufacturer is marketing
Bijuva as "the first and only FDA-approved combination
of bio-identical estradiol and bio-identical progesterone
in a single daily oral capsule".
Meloxicam (Mobic) for Osteoarthritis
The Medical Letter on Drugs and Therapeutics • May 29, 2000 (Issue 1079)
NSAIDs
Drug Usual dosage for osteoarthritis Cost
1
Celecoxib − Celebrex (Searle) 200 mg/day $72.60 ...
Meloxicam, a nonsteroidal anti-inflammatory drug (NSAID) with some cyclooxygenase-2 (COX-2) selectivity in vitro, has been approved by the FDA for treatment of osteoarthritis.
Quartette: An Ascending-Dose, Extended-Cycle Oral Contraceptive
The Medical Letter on Drugs and Therapeutics • Jul 08, 2013 (Issue 1420)
(0.03 mg or 0.02
mg) for 84 days. All regimens included 7 days of 0.01 mg
of EE alone on days 85-91 ...
The FDA has approved Quartette (Teva), an extended-cycle
combination oral contraceptive containing increasing
doses of the estrogen ethinyl estradiol (EE)
combined with the progestin levonorgestrel (LNG). The
rationale is that a gradual increase in the EE dose may
reduce unscheduled bleeding or spotting, a common
adverse effect of extended-cycle oral contraceptives.
Antiviral Drugs for Varicella-Zoster Virus and Herpes Simplex Virus Infections
The Medical Letter on Drugs and Therapeutics • Sep 24, 2018 (Issue 1556)
within 6 days of
lesion onset decreases the duration of pain and
constitutional symptoms, viral ...
The recommendations for treatment of varicella-zoster
virus (VZV) and herpes simplex virus (HSV)
infections are listed in tables 1 and 2. Vaccination
against VZV was reviewed in a previous issue.
Venlafaxine - A New Antidepressant
The Medical Letter on Drugs and Therapeutics • Jun 10, 1994 (Issue 924)
metabolite reach steady-state concentrations in plasma within three days.
CLINICAL TRIALS — A double-blind ...
Venlafaxine hydrochloride (Effexor - Wyeth-Ayerst) was recently approved by the US Food and Drug Administration for treatment of depression. An aminomethyl-benzyl- cyclohexanol, it is chemically related to bupropion (Wellbutrin).
Comparison Table: Some Parenteral Anticoagulants for VTE (online only)
The Medical Letter on Drugs and Therapeutics • Jul 25, 2022 (Issue 1655)
for treatment of VTE. UFH can be
stopped after a minimum of 5 days when
INR is ≥2 for at least 24 hours ...
View the Comparison Table: Some Parenteral Anticoagulants for VTE
Fenfluramine (Fintepla) for Dravet Syndrome
The Medical Letter on Drugs and Therapeutics • Aug 09, 2021 (Issue 1630)
Fenfluramine 0.2 mg/kg/day -32.4%* 38%*
Fenfluramine 0.7 mg/kg/day -62.3%* 68%*
Placebo 12%
Study 2 (15 ...
The FDA has approved fenfluramine oral solution
(Fintepla – Zogenix) for treatment of seizures in
patients ≥2 years old with Dravet syndrome. It is the
third drug to be approved for this indication. Stiripentol
(Diacomit) and cannabidiol (Epidiolex), a purified
product derived from marijuana, were approved earlier.
Comparison Table: Some Lipid-Lowering Drugs (online only)
The Medical Letter on Drugs and Therapeutics • Sep 19, 2022 (Issue 1659)
Atorvastatin – generic
Lipitor (Pfizer)
10, 20, 40, 80 mg tabs Initial: 10-20 mg PO once/day
Maximum: 80 mg ...
View the Comparison Table: Some Lipid-Lowering Drugs
Topical Drugs For Vaginal Candidiasis
The Medical Letter on Drugs and Therapeutics • Aug 23, 1991 (Issue 851)
grams at bedtime x 6 days
(pregnant)
x 3 days (nonpregnant)
28 gm − $16.63
15 gm − 17.59
Femstat ...
Many drugs, mostly imidazole derivatives, are marketed in the USA for topical treatment of vulvovaginal candidiasis, and a few are now available without a prescription.
Valacyclovir
The Medical Letter on Drugs and Therapeutics • Jan 05, 1996 (Issue 965)
1,000 mg t.i.d. for either seven or 14 days, or acyclovir 800 mg five times per day
for seven days ...
Valacyclovir (Valtrex - Glaxo Wellcome), an L- valyl ester of acyclovir (Zovirax), has been approved by the US Food and Drug Administration (FDA) for oral treatment of herpes zoster (shingles) in immunocompetent adults. Famciclovir (Famvir - Medical Letter, 36:97, 1994) is also available for this indication.